Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$1.3 - $2.49 $13,000 - $24,900
10,000 New
10,000 $10,000
Q1 2022

May 12, 2022

SELL
$1.35 - $2.88 $18,630 - $39,744
-13,800 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.72 - $5.72 $7,888 - $16,588
-2,900 Reduced 17.37%
13,800 $54,000
Q3 2021

Nov 10, 2021

BUY
$4.83 - $7.2 $80,661 - $120,240
16,700 New
16,700 $44,000

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $61.4M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.